Instituto Nacional de Câncer

Rio de Janeiro 20231-050

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Colorectal Cancer, Esophageal Neoplasms, Lymph Node Metastases, Metastatic Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• Distribution of Lymph Node Metastases in Esophageal Carcinoma — Recruiting now
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation — Running, not enrolling
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early